UY39446A - Micro-nano particles based on dimethyltryptamines and a natural inhibitor of the MAO enzyme - Google Patents
Micro-nano particles based on dimethyltryptamines and a natural inhibitor of the MAO enzymeInfo
- Publication number
- UY39446A UY39446A UY0001039446A UY39446A UY39446A UY 39446 A UY39446 A UY 39446A UY 0001039446 A UY0001039446 A UY 0001039446A UY 39446 A UY39446 A UY 39446A UY 39446 A UY39446 A UY 39446A
- Authority
- UY
- Uruguay
- Prior art keywords
- nano particles
- micro
- dimethyltryptamines
- natural inhibitor
- particles based
- Prior art date
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
La presente invención se refiere a un proceso de obtención de micro-nano partículas para la encapsulación de DMT/5-MeO-DMT o sus sales derivadas farmacéuticamente aceptables en conjunto con un inhibidor natural de la enzima Monoamino oxidasa (MAO), en dosis terapeuticamente efectivas, para ser usadas en diferentes formulaciones farmacéuticas, para el tratamiento personalizado de trastornos neurológicos y/o psiquiátricos, y/o desórdenes inflamatorios.The present invention relates to a process for obtaining micro-nano particles for the encapsulation of DMT/5-MeO-DMT or its pharmaceutically acceptable salts derived therefrom together with a natural inhibitor of the enzyme Monoamine oxidase (MAO), in therapeutically effective doses, to be used in different pharmaceutical formulations, for the personalized treatment of neurological and/or psychiatric disorders, and/or inflammatory disorders.
Priority Applications (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| UY0001039446A UY39446A (en) | 2021-09-30 | 2021-09-30 | Micro-nano particles based on dimethyltryptamines and a natural inhibitor of the MAO enzyme |
| EP21218287.7A EP4159201A1 (en) | 2021-09-30 | 2021-12-30 | Encapsulated microparticles and nanoparticles of dimethyltriptamines |
| US18/697,499 US20240408063A1 (en) | 2021-09-30 | 2022-09-29 | Encapsulated microparticles and nanoparticles of dimethyltriptamines |
| PCT/CA2022/051451 WO2023050010A1 (en) | 2021-09-30 | 2022-09-29 | Encapsulated microparticles and nanoparticles of dimethyltryptamines |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| UY0001039446A UY39446A (en) | 2021-09-30 | 2021-09-30 | Micro-nano particles based on dimethyltryptamines and a natural inhibitor of the MAO enzyme |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| UY39446A true UY39446A (en) | 2023-04-28 |
Family
ID=96171731
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| UY0001039446A UY39446A (en) | 2021-09-30 | 2021-09-30 | Micro-nano particles based on dimethyltryptamines and a natural inhibitor of the MAO enzyme |
Country Status (1)
| Country | Link |
|---|---|
| UY (1) | UY39446A (en) |
-
2021
- 2021-09-30 UY UY0001039446A patent/UY39446A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP4570320A3 (en) | Bifunctional compounds for degrading btk via ubiquitin proteosome pathway | |
| MX2024008539A (en) | Bifunctional compounds for degrading btk via ubiquitin proteosome pathway. | |
| UY39857A (en) | LIPIDATED PEPTIDE INHIBITORS OF THE INTERLEUKIN-23 RECEPTOR | |
| UY27755A1 (en) | NEW PHARMACEUTICAL COMPOSITIONS BASED ON ANTICHOLINERGICS AND INHIBITORS. | |
| MY208662A (en) | Modulators of methyl modifying enzymes, compositions and uses thereof | |
| AR116753A1 (en) | PREPARATION PROCESS OF A PYRAZOLSULFONYLAMIDE DERIVATIVE | |
| CY1117995T1 (en) | SECONDARY PRODUCTS OF CATEGOLAMIN AND MEDICINES CONTAINING THE THESE COMPOUNDS | |
| CY1115286T1 (en) | TOY PARKINSON'S DISEASE TREATMENT METHODS | |
| PA8504801A1 (en) | NEW USEFUL BIARILETER DERIVATIVES AS INHIBITORS OF MONOAMINE RECOVERY | |
| EA202193012A1 (en) | ROUTES OF ADMINISTRATION OF CERTAIN VMAT2 INHIBITORS | |
| ECSP056019A (en) | 2,4-DI (PHENYLAMINE) USEFUL PYRIMIDINS IN THE TREATMENT OF NEOPLASTIC DISEASES, INFLAMMATORY DISORDERS AND THE IMMUNE SYSTEM | |
| PE20230091A1 (en) | THERAPEUTIC CONJUGATES | |
| UY27993A1 (en) | DERIVATIVES OF 4-PIRROLIDINO-FENIL-BENCIL ETER | |
| UY39446A (en) | Micro-nano particles based on dimethyltryptamines and a natural inhibitor of the MAO enzyme | |
| CL2024003328A1 (en) | Methods for the treatment of lymphoma. | |
| TWD209426S (en) | The base of the mask transfer box | |
| WO2023069514A9 (en) | Bifunctional compounds for degrading itk via ubiquitin proteosome pathway | |
| MD4637B1 (en) | Method for producing hyaluronidase conjugate with polyethylenepiperazine derivatives and the use of the conjugate produced | |
| CL2025000075A1 (en) | 1,3,4-Oxadiazole derivative compounds that are selective inhibitors of histone deacetylase 6. | |
| SE9804126D0 (en) | New pharmaceutical composition | |
| TWD217045S (en) | Susceptor support | |
| DE50312224D1 (en) | DEUTERATED CATECHOLAMINE DERIVATIVES AND MEDICAMENTS CONTAINING SUCH COMPOUNDS | |
| NO20073610L (en) | Newly substituted thiophenpyrimidinone derivatives as inhibitors of 17β-hydroxysteroid dehydrogenase | |
| TWD204496S (en) | Substrate retaining ring | |
| SE0202365D0 (en) | New formulation and use thereof |